Stocks and Investing
Stocks and Investing
Wed, September 25, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Michael Leithead Maintained (CC) at Hold with Decreased Target to $21 on, Sep 25th, 2024
Michael Leithead of Barclays, Maintained "The Chemours Company" (CC) at Hold with Decreased Target from $22 to $21 on, Sep 25th, 2024.
Michael has made no other calls on CC in the last 4 months.
There are 5 other peers that have a rating on CC. Out of the 5 peers that are also analyzing CC, 3 agree with Michael's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Duffy Fischer of "Goldman Sachs" Maintained at Hold with Decreased Target to $23 on, Tuesday, September 3rd, 2024
- Jeffrey Zekauskas of "JP Morgan" Maintained at Hold with Decreased Target to $18 on, Tuesday, August 6th, 2024
- John Roberts of "Mizuho" Initiated at Hold and Held Target at $25 on, Friday, June 7th, 2024
These are the ratings of the 2 analyists that currently disagree with Michael
- John McNulty of "BMO Capital" Maintained at Buy with Decreased Target to $30 on, Tuesday, August 6th, 2024
- Joshua Spector of "UBS" Maintained at Strong Buy with Decreased Target to $28 on, Tuesday, August 6th, 2024
Contributing Sources